Biochemical algorithm to identify individuals with ALPL variants among subjects with persistent hypophosphatasaemia

Denise Goodbar March 22, 2022

0 Comments

To read more please click on the link below.
Read Article

Categories: Scientific Publications, Scientific Publications (new)

Tags: alkaline phosphatase, ALPL, hypophosphatasaemia, hypophosphatasia, Metabolic bone diseases

Can we identify individuals with an ALPL variant in adults with persistent hypophosphatasaemia?

To read more please click on the link below. Read Article

Denise Goodbar November 5, 2020

0 Comments

Biochemical, clinical and genetic characteristics in adults with persistent hypophosphatasaemia; Data from an endocrinological outpatient clinic in Denmark

To read more please click on the link below. Read Article

Denise Goodbar July 14, 2021

0 Comments

Systemic Effects of Hypophosphatasia. Characterization of Two Novel Variants in the Alpl Gene

To read more please click on the link below. Read Article

Margaret Robb November 22, 2023

0 Comments

The Global ALPL gene variant classification project: Dedicated to deciphering variants

To read more please click on the link below. Read Article

Margaret Robb January 23, 2024

0 Comments

New insights into the landscape of ALPL gene variants in patients with hypophosphatasia from the Global HPP Registry

To read more please click on the link below. Read Article

Margaret Robb August 15, 2024

0 Comments

Responses

You must be logged in to post a comment.

Mail Address
The US Hypophosphatasia Foundation
141 Hawkins Place, #267
Boonton, NJ 07005, USA.

Organization

Programs

Community

Office Address
1719 NJ-10, Suite 315
Parsippany, NJ 07054

Follow Us on Social Media!

Disclaimer: This Website is owned by Soft Bones, Inc. All materials contained in this Website (the “Materials”) are either owned by or licensed to us and are protected by intellectual property and other laws. We retain all proprietary rights to the Materials. This Website is copyrighted. All rights are reserved. Except as expressly authorized by us, any use, copy, reproduction, display, performance, modification or retransmission of the Materials is strictly prohibited.

Related Articles

Responses